期刊文献+

车前子对Wistar高尿酸大鼠降尿酸的机制研究 被引量:26

暂未订购
导出
摘要 目的研究中药制剂车前子对Wistar高尿酸大鼠降尿酸的作用。方法将20只雄性Wistar大鼠随机分为正常对照组、模型组、阳性药物组和车前子组,每组5只,用氧嗪酸钾盐建立高尿酸血症大鼠模型。测定各组血尿酸(Ur)、肌酐(Cr)和尿素氮(BUN)的水平。结果模型组的尿酸值为最高,明显高于其它各组(P<0.01);与模型组比较,阳性药物组和车前子组血尿酸水平差异具有明显统计学意义(P<0.01);与模型组比较,车前子组能明显抑制黄嘌呤氧化酶活性差异具有统计学意义(P<0.05)。结论车前子对氧嗪酸钾盐所致Wistar大鼠高尿酸血症的降尿酸作用机制可能在于对肝脏黄嘌呤氧化酶的抑制作用。
作者 郑璇 孙红
机构地区 福建省立医院
出处 《福建中医药》 2010年第6期52-53,共2页 Fujian Journal of Traditional Chinese Medicine
基金 福建省卫生厅青年科研课题(2010-1-3)
  • 相关文献

参考文献4

  • 1KONG L D,YANG C,GE F,et al.A Chinese herbal medicine Ermiao wan reduces serum uric acid level and inhibits liver xanthin dehydrogenase and xanthine oxidase in mice[J].Journal of Ethnopharmacology,2004,93 (2-3):325-330.
  • 2何立群,聂永红,邹士林.新型尿酸性肾病动物模型的建立[J].上海实验动物科学,2001,21(1):22-25. 被引量:32
  • 3喻志峰,杨澄,仇熙,陈琰,孔令东,王明时.瑞香苷对高尿酸血症小鼠的影响[J].中国药科大学学报,2002,33(2):142-145. 被引量:32
  • 4BLUESTON R,WALSMAN J,KLINENBERG J R.Chronic experimental Hyperuricemic nephropathy[J].Lab Invest,1975,33 (3):273-279.

二级参考文献20

  • 1[1]Star VL, Hochberg M. Prevention and management of gout. Drug,1993, 45:212-222.
  • 2[2]Wortmann RL, Management of hyperuricemia. In: McCarthy DJ, Koopman WJ, Arthritis and allied conditions 12th ed., Philadelphia, Lea and Febiger, 1993. 1807-1818.
  • 3[3]Campion EW, Glynn RJ,DeLabry LO. A symptomatic hyper-uricemia: risks and consequences in the normative again study [J]. Am J Med,1987,82:421-424.
  • 4[4]Li Y, Stamler J, Xiao Z, et al. Serum uric acid and its correlates in Chinese adult populations, urban and rural, of Beijing: the PRC-USA collaborative study in cardiovascular and cardiopulmonary epidemiology. Int J Epidemiol,1997,26:288-296.
  • 5[5]Kelley WN. Antihyperuricemic drugs. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, Textbook of Rheumatology, Philadelphia, WB Saunders, 1991,862-877.
  • 6[6]Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity: des-cription and guidelines for prevention in patients with renal insufficiency. Am J Med, 1984,76:47-50.
  • 7[7]Hande KR,Noone RM,Stone WJ. Severe allopurinol toxicity: description and guidelines for prevenyion in patients with renal insufficiency. American Journal of Medicine,1984,76: 47-52.
  • 8[8]Urban T, Maquarre E, Housset C, et al. Allopurinol hypersensitivity. A possible cause of hepatitis and mucocutaneous eruptions in a patient undergoing antitubercular treatment. Revue des Maladies Respiratoires, 1995,12:314-316.
  • 9[9]Chang WS, Lin CC, Chuang SC, et al. Superoxide anion scavenging effect of coumarins. American Journal of Chinese Medicine, 1996, 24(1):11-17.
  • 10[10]Chang WS, Chang YH, Lu FJ, et al. Inhibitory effects of phenolics on xanthine oxidase. Anticancer Research, 1994,14:501-506.

共引文献58

同被引文献313

引证文献26

二级引证文献453

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部